Stockscreener 앱 받기
0.42
1.20%
0.005
전일 마감가:
$0.415
열려 있는:
$0.42
하루 거래량:
20,761
Relative Volume:
0.26
시가총액:
$6.05M
수익:
$2.37M
순이익/손실:
$-11.49M
주가수익비율:
-0.4498
EPS:
-0.9338
순현금흐름:
$-10.02M
1주 성능:
-6.67%
1개월 성능:
+2.44%
6개월 성능:
-81.17%
1년 성능:
-78.24%
1일 변동 폭
$0.4101
$0.42
1주일 범위
$0.39
$0.4574
52주 변동 폭
$0.2711
$4.98
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Compare CLGN vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
0.42 | 5.98M | 2.37M | -11.49M | -10.02M | -0.9338 |
VRTX
Vertex Pharmaceuticals Inc
|
440.71 | 110.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
629.57 | 66.53B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
828.64 | 50.27B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.19 | 39.45B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
152.60 | 32.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-02-17 | 개시 | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd 주식(CLGN)의 최신 뉴스
CLGN Q4 2025 Earnings: Miss on EPS as Pre-Revenue Biotech Advances PipelineViral Trade Signals - Newser
CLGN Q1'26 Earnings: revenue estimate is 460.00K USD - TradingView
TradingKey - TradingKey
D. Boral Capital Maintains CollPlant Biotechnologies (CLGN) Buy Recommendation - MSN
CLGN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Hugh M. Evans (CLGN) details CollPlant share, RSU and option holdings - Stock Titan
[EFFECT] CollPlant Biotechnologies Ltd SEC Filing - Stock Titan
CollPlant (CLGN) registers 3.296M shares for resale; warrants convertible into shares - Stock Titan
CollPlant (CLGN) Stock: Investment Potential Insight (Climbs) 2026-04-20Social Buzz Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Jasmine Seror Net Worth (2026) - GuruFocus
Avraham Havron Net Worth (2026) - GuruFocus
Elan Penn Net Worth (2026) - GuruFocus
Bowman Bagley Net Worth (2026) - GuruFocus
Bar Berta Abelis Net Worth (2026) - GuruFocus
Eran Rotem Net Worth (2026) - GuruFocus
Oren Fahimipoor Net Worth (2026) - GuruFocus
Philippe Bensimon Net Worth (2026) - GuruFocus
Yehiel Tal Net Worth (2026) - GuruFocus
CollPlant (NASDAQ: CLGN) registers 3.296M resale shares; warrants detail - Stock Titan
CLGN SEC FilingsCollplant Biotechnologies Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Momentum Shift: Can CollPlant Biotechnologies Ltd sustain earnings growthGap Up & Trade Opportunity Analysis Reports - baoquankhu1.vn
CollPlant implementing cost-reduction and workforce optimization plan - TipRanks
CLGN Implements Major Cost-Cutting Measures for Future Growth - GuruFocus
CollPlant Ends AbbVie Partnership, Eyes New Opportunities Ahead - Intellectia AI
CollPlant Resets Strategy After AbbVie Ends Filler Deal, Slashes Workforce by 50% - TipRanks
CollPlant ends AbbVie deal, cuts workforce by 50% By Investing.com - Investing.com South Africa
CollPlant announces termination of development agreement with AbbVie - TipRanks
AbbVie ends CollPlant (NASDAQ: CLGN) filler pact as CollPlant slashes workforce 50% - Stock Titan
CollPlant Biotechnologies Ltd and Allergan Industrie SAS Terminate Development Agreement - marketscreener.com
CollPlant Issues Letter to Shareholders (2026-04-13) - Seeking Alpha
Is CollPlant (CLGN) Stock Leading the Market | Price at $0.34, Down 10.99%Money Flow - Newser
Buyback Watch: Does CollPlant Biotechnologies Ltd stock have upside surprise potentialCEO Change & Capital Protection Trading Alerts - baoquankhu1.vn
Is CollPlant (CLGN) Stock in a Selling Zone | Price at $0.41, Up 6.77%Fibonacci Retracement - Newser
Aug Swings: What is CollPlant Biotechnologies Ltds debt to equity ratioEarnings Recap Summary & High Return Trade Guides - baoquankhu1.vn
Will CollPlant (CLGN) Stock Outperform S&P 500 | Price at $0.50, Down 5.48%Hedge Fund Inspired Picks - Newser
CLGN Stock Analysis: CollPlant Biotechnologies 0.53 Daily Dip Performance Update - Newser
CollPlant Files to Sell 3.3M Ordinary Shares - Intellectia AI
CollPlant Biotechnologies (NASDAQ: CLGN) registers 3.296M shares for resale - Stock Titan
Collplant Biotechnologies Ltd reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets
CollPlant Biotechnologies Details 2025 Results, Bioprinting Launch and Regenerative Implant Progress - TipRanks
CollPlant Biotechnologies (NASDAQ:CLGN) Stock Surges on Q4 Revenue Beat - ChartMill
CollPlant Biotechnologies (NASDAQ: CLGN) 20-F warns on going concern and cash - Stock Titan
COLLPLANT BIOTECHNOLOGIESNEW ($CLGN) Releases Q4 2025 Earnings - Quiver Quantitative
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Nasdaq
CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Profit Outlook - simplywall.st
CollPlant Biotechnologies Faces Nasdaq Bid-Price Deficiency, Granted Compliance Window - TipRanks
CollPlant (CLGN) receives Nasdaq minimum bid-price notice, given time to cure - Stock Titan
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement - PR Newswire
CollPlant Biotechnologies (CLGN) CEO Tal Yehiel details option and RSU holdings - Stock Titan
CollPlant (CLGN) director Alisa Lask details option and RSU holdings - Stock Titan
Collplant Biotechnologies Ltd (CLGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
1.91%
자본화:
|
볼륨(24시간):